 | Up a level |
2016
Domchek, Susan M., Aghajanian, Carol, Shapira-Frommer, Ronnie, Schmutzler, Rita K., Audeh, M. William, Friedlander, Michael, Balmana, Judith 
ORCID: 0000-0002-0762-6415, Mitchell, Gillian, Fried, Georgeta, Stemmer, Salomon M., Hubert, Ayala, Rosengarten, Ora, Loman, Niklas, Robertson, Jane D., Mann, Helen and Kaufman, Bella
(2016).
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy.
Gynecol. Oncol., 140 (2).
S. 199 - 204.
SAN DIEGO:
ACADEMIC PRESS INC ELSEVIER SCIENCE.
ISSN 1095-6859
2015
Kaufman, Bella, Shapira-Frommer, Ronnie, Schmutzler, Rita K., Audeh, M. William, Friedlander, Michael, Balmana, Judith ORCID: 0000-0002-0762-6415, Mitchell, Gillian, Fried, Georgeta, Stemmer, Salomon M., Hubert, Ayala, Rosengarten, Ora, Steiner, Mariana, Loman, Niklas, Bowen, Karin, Fielding, Anitra and Domchek, Susan M.
(2015).
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation.
J. Clin. Oncol., 33 (3).
S. 244 - 251.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
2011
Domchek, Susan M., Mitchell, Gillian, Lindeman, Geoffrey J., Tung, Nadine M., Balmana, Judith ORCID: 0000-0002-0762-6415, Isakoff, Steven J., Schmutzler, Rita, Audeh, M. William, Loman, Niklas, Scott, Clare, Friedlander, Michael, Kaufman, Bella, Garber, Judy E., Tutt, Andrew ORCID: 0000-0001-8715-2901 and Robson, Mark E.
(2011).
Challenges to the Development of New Agents for Molecularly Defined Patient Subsets: Lessons From BRCA1/2-Associated Breast Cancer.
J. Clin. Oncol., 29 (32).
S. 4224 - 4227.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755